Patients should be careful with the way BPC-157 is marketed online
Nausea (most common, especially during first 1 to 2 weeks of a new dose) Diarrhea or, just as often, constipation Vomiting (less common but more likely at 9 to 12 mg) Reduced appetite, food noise quieting down (this is the goal, not a side effect) Skin sensitivity (dysesthesia): tingling, prickly feeling, or sunburn-like skin
These side effects include cataracts, steroid-induced diabetes, and bone problems such as osteoporosis and avascular necrosis (AVN), a condition in which the bone dies due to inadequate blood supply
Swirl gently until fully dissolved
These molecules are hypothesized to potentially play significant roles in cell growth, migration, and angiogenesis
In published preclinical work, KPV has been studied for inhibiting NF-B activation in intestinal epithelial cells, with one widely cited study showing PepT1-mediated transport into colonic cells as part of its anti-inflammatory mechanism in mouse colitis models (Dalmasso et al., Gastroenterology , 2008)
